Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker
Cancer is a systemic disease involving multiple components produced from both tumor cells themselves and surrounding stromal cells. The pro- or anti-tumoral role of the stroma is still under debate. Indeed, it has long been considered the main physical barrier to the diffusion of chemotherapy by its...
Main Authors: | Sophie Liot, Alexandre Aubert, Valérie Hervieu, Naïma El Kholti, Joost Schalkwijk, Bernard Verrier, Ulrich Valcourt, Elise Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Matrix Biology Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590028520300028 |
Similar Items
-
Latent TGF-β Activation Is a Hallmark of the Tenascin Family
by: Alexandre Aubert, et al.
Published: (2021-05-01) -
Early Days of Tenascin-R Research: Two Approaches Discovered and Shed Light on Tenascin-R
by: Fritz G. Rathjen, et al.
Published: (2021-01-01) -
The role of serum tenascin-c and procalcitonin in predicting the severity of acute pancreatitis
by: Adil Ugur Cetin, et al.
Published: (2021-06-01) -
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers
by: Ismaïl Hendaoui, et al.
Published: (2021-02-01) -
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
by: Sophie Liot, et al.
Published: (2021-04-01)